Not finding it? Sign in to also search OpenAlex live.
-
Definition of resectable stage III non-small cell lung cancer (NSCLC) for inclusion in clinical trials: A clinical case review by a pan-European multidisciplinary expert panel led by the EORTC Lung Cancer Group
Mariana Brandão, Elena Prisciandaro, Eleni Xenophontos, Alessio Vincenzo Mariolo, Amir H. Sadeghi, Andrea Riccardo Filippi, +45 more
11citations -
Variation Between Multidisciplinary Tumor Boards in Clinical Staging and Treatment Recommendations for Patients With Locally Advanced Non-small Cell Lung Cancer
Fieke Hoeijmakers, David Jonathan Heineman, Johannes M. A. Daniels, Naomi Beck, Rob A.�E.�M. Tollenaar, Michel W.J.M. Wouters, +11 more
35citations -
Consensus definition of stage III non-small-cell lung cancer technical resectability to standardise inclusion criteria for clinical trials: a multisocietal EORTC-Lung Cancer Group collaboration2026 The Lancet Respiratory Medicine article Medicine Lung Cancer Diagnosis and Treatment Open access
Anne‐Marie C. Dingemans, Isabelle Opitz, Alessandro Brunelli, Jordi Remón, Lizza E.L. Hendriks, John Edwards, +30 more
11citations -
P21.03 Dutch Lung Cancer Audit-Radiotherapy: Real-World Data on Stage III Non-Small Cell Lung Cancer Treated With Radiotherapy Only2021 Journal of Thoracic Oncology conference-abstract Medicine Lung Cancer Diagnosis and Treatment Open access
Liselotte van Bockel, Lucas H. V. van der Woude, Katrien De Jaeger, Ida E.M. Coremans, Ronald A.M. Damhuis, C. Van Es, +16 more
1citations -
Survival difference between patients with single versus multiple metastatic lymph nodes and the role of histology in pathological stage II-N1 non-small cell lung cancer
Julianne Cynthia de Ruiter, Adrianus Johannes De Langen, Kim Monkhorst, Alexander Veenhof, Houke M. Klomp, Jasper Smit, +3 more
3citations -
Corrigendum to “Trends and variations in the treatment of stage I-III small cell lung cancer from 2008 to 2019: A nationwide population-based study from the Netherlands” [Lung Cancer 162C (2021) 61–70]
Jelle Evers, Lizza E.L. Hendriks, Katrien De Jaeger, Robin Wijsman, Dirk De Ruysscher, Chris H.J. Terhaard, +4 more
1citations -
Patients’ Preferences Regarding Invasive Mediastinal Nodal Staging of Resectable Lung Cancer2021 Patient Preference and Adherence article Medicine Lung Cancer Diagnosis and Treatment Open access
Jelle E. Bousema, Fieke Hoeijmakers, Marcel G. W. Dijkgraaf, Jouke Tabe Annema, Frank J.C. van den Broek, M. Elske van den Akker‐van Marle
4citations -
119MO Phase I/II trial evaluating the innovative therapeutic cancer vaccine PDC*lung01 in combination with anti-PD-1 in patients (pts) with untreated stage IV non-small cell lung cancer2024 Immuno-Oncology Technology article Immunology and Microbiology Immunotherapy and Immune Responses Open access
J.F. Vansteenkiste, Kristof Cuppens, I. Demedts, F. Borm, B. Biesma, Maurice Pérol, +13 more
0citations -
Prevalence, clinical and molecular characteristics of early stage EGFR-mutated lung cancer in a real-life West-European cohort: Implications for adjuvant therapy
Liesbeth M. Hondelink, Sophie M. Ernst, Peggy N. Atmodimedjo, Danielle B. Cohen, Janina L Wolf, Anne‐Marie C. Dingemans, +2 more
33citations -
Stage I non-small cell lung cancer: improving patient selection for minimally invasive lobectomy or stereotactic ablative radiotherapy based on clinical characteristics
Julianne Cynthia de Ruiter, Vincent van der Noort, Judi N.A. van Diessen, Egbert Frederik Smit, Ronald A.M. Damhuis, Koen Johan Hartemink, +90 more
0citations